Login
← Go Back
JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025
Stock Price vs Company Growth
1d
3.9%
1w
5.9%
1m
4.9%
3m
20.9%
6m
28.7%
all
35.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 8.7 3.9%
8.55
11.2
Company Overview
Sales
80.1 Cr
Growth: 0.9%
Profit after Tax
4.82 Cr
Growth: 36.0%
Micro Cap
28.7 Cr
P/E: 5.9x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 80.1
Growth 0.9%
EBITDA 12.0%
P/S 0.4x
Dividend 0.0%
P/E 5.9x
Book Value ₹ 10
PEG Ratio 6.4x
ROE 14.6%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)